Francesco Versaci
Francesco Versaci is an expert in Cardiology at Ospedale Santa Maria Goretti (Italy). As of October 2026, ScienceLeadR ranks Francesco Versaci in the top 1% of experts worldwide for Myocardial Ischemia. Francesco Versaci has authored 328 publications, the most recent in 2026, and is an investigator in 9 clinical trials, 3 of them ongoing. SLR score: 1,026 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Public Health - Pharmacy - Medical Imaging
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1996 - 2026
Number : 328
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| A Survey on Perspectives Toward Artificial Intelligence Among Italian Interventional Cardiologists. PMID 42795823 — trust, intelligence, education, medical, workflow, percutaneous coronary intervention, machine learning, physicians, decision support systems, clinical, cardiologists, technology assessment, biomedical, artificial intelligence, education | J Clin Med | 2026 | 0 |
| Complete Revascularization Guided by Functional Coronary Angiography in STEMI. PMID 42670979 — coronary angiography, physiology, safety, stroke, myocardial infarction, angiography, arteries, st elevation myocardial infarction, accidents, ischemia | N Engl J Med Top journal | 2026 | 0 |
| Giant Thrombosed Coronary Aneurysm Causing Recurrent Ischemic Events: Insights From Multimodality Imaging and Surgical Management. PMID 42606398 — myocardial infarction, tomography, aneurysm, angiography, arteries, coronary aneurysm, coronary artery bypass, diagnosis, thrombosis, anatomy, computed tomography angiography | JACC Case Rep | 2026 | 0 |
| ApoC-III Inhibition in Hypertriglyceridemia: From Triglyceride Lowering to Clinical Risk Modification. PMID 42566359 — cardiovascular agents, hypertriglyceridemia, apolipoproteins c, triglycerides | J Cardiovasc Pharmacol | 2026 | 0 |
| SGLT2 inhibitors after transcatheter aortic valve implantation: a systematic review and exploratory meta-analysis. PMID 42433614 — sodium-glucose transporter 2 inhibitors, aortic valve, transcatheter aortic valve replacement | Int J Cardiol Heart Vasc | 2026 | 1 |
Clinical Studies 9
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Ongoing Clinical Trials
3 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Sodium glucose cotransporter 2 inhibitors to stabilize coronary ather osclerosis progression after acute myocardial infarction in women and men with diabetes mellitus 2025-523375-29-00 — diabetes mellitus, sodium-glucose transport proteins, myocardial infarction, atherosclerosis, men, women | Phase 3 | Recruiting | 2026 |
| REnal Denervation After Stroke (REDs) Study A Randomized Clinical Trial of Renal Denervation in the Subacute Phase of Stroke NCT07114757 — sympathectomy, hypertension, quality of life, blood, denervation, stroke, cardiovascular diseases, blood pressure, nerve fibers, antihypertensive agents, aged, cerebrovascular disorders, random allocation, catheters | N/A | Not yet recruiting | 2025 |
| Functional Coronary Angiography Guided Revascularization in STEMI NCT05818475 — coronary angiography, physiology, myocardial infarction, percutaneous coronary intervention, angiography, st elevation myocardial infarction, therapeutics, angiography-derived physiology | N/A | Active not recruiting | 2023 |
LeadR Networks
Main global connection map